Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions
Hayley F. North, Jason Bruggemann, Vanessa Cropley, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 4, pp. 595-607
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis
Saahithh Redddi Patlola, Gary Donohoe, Declan P. McKernan
Journal of Psychiatric Research (2023) Vol. 160, pp. 126-136
Closed Access | Times Cited: 42
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
Caitlin E. Murphy, Adam K. Walker, Cynthia Shannon Weickert
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 83
The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis
Saahithh Redddi Patlola, Gary Donohoe, Declan P. McKernan
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110668-110668
Closed Access | Times Cited: 68
The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis
Manuel Morrens, C. Overloop, Violette Coppens, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 8, pp. 3237-3246
Open Access | Times Cited: 52
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity
Paris Alexandros Lalousis, Lianne Schmaal, Stephen J. Wood, et al.
Brain Behavior and Immunity (2023) Vol. 113, pp. 166-175
Open Access | Times Cited: 23
A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone
Hayley F. North, Christin Weissleder, Janice M. Fullerton, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 55
Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia
Yunting Zhu, Maree J. Webster, Adam K. Walker, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 46-60
Closed Access | Times Cited: 17
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
Daniella Dwir, Inès Khadimallah, Lijing Xin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 5, pp. 309-321
Open Access | Times Cited: 17
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise
Jacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Schizophrenia Research Cognition (2024) Vol. 38, pp. 100328-100328
Open Access | Times Cited: 6
Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia
Elżbieta Kozłowska, Ewa Brzezińska‐Błaszczyk, Justyna Agier, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 380-387
Open Access | Times Cited: 39
Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
Jessica Gracias, Funda Orhan, Elin Hörbeck, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 14
An overview of the relationship between inflammation and cognitive function in humans, molecular pathways and the impact of nutraceuticals
Chusana Mekhora, Daniel J. Lamport, Jeremy P.E. Spencer
Neurochemistry International (2024) Vol. 181, pp. 105900-105900
Open Access | Times Cited: 5
Peripheral complement is increased in schizophrenia and inversely related to cortical thickness
Ellen Ji, Danny Boerrigter, Helen Cai, et al.
Brain Behavior and Immunity (2021) Vol. 101, pp. 423-434
Closed Access | Times Cited: 30
Increased immune cell and altered microglia and neurogenesis transcripts in an Australian schizophrenia subgroup with elevated inflammation
Hayley F. North, Christin Weissleder, Janice M. Fullerton, et al.
Schizophrenia Research (2022) Vol. 248, pp. 208-218
Closed Access | Times Cited: 19
Genetic Overlap Between Global Cortical Brain Structure, C-Reactive Protein, and White Blood Cell Counts
Nadine Parker, Weiqiu Cheng, Guy Hindley, et al.
Biological Psychiatry (2023) Vol. 95, Iss. 1, pp. 62-71
Open Access | Times Cited: 11
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial
Thomas W. Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 191-200
Open Access | Times Cited: 11
Social isolation and cognitive function in patients with schizophrenia: A two years follow-up study
Bin Yu, Zhengqi Sun, Shen Li, et al.
Schizophrenia Research (2024) Vol. 267, pp. 150-155
Closed Access | Times Cited: 4
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation
Jacopo Sapienza, Giulia Agostoni, Federica Repaci, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 176-176
Open Access
The Effect of Electroconvulsive and Magnetic Seizure Therapy (MST) on Cortical Thickness in Schizophrenia
Jin Li, Junjie Wang, Yang Yong, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Immunity and neuroinflammation in early stages of life and epilepsy
Anastacia M. Garcia, María Leonor López‐Meraz, Marco I. González, et al.
Epilepsia (2025)
Closed Access
Investigating the relationship between toll-like receptor activity, low-grade inflammation and cognitive deficits in schizophrenia patients – A mediation analysis
Saahithh Redddi Patlola, Laurena Holleran, Maria R. Dauvermann, et al.
Brain Behavior and Immunity (2025)
Closed Access
Thinning of the temporal and insular cortex is associated with negative symptoms and impaired attention in Chinese chronic schizophrenia patients with deficit syndrome
Jin Li, Xiao‐Bin Zhang, Junjie Wang, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Disturbed Functional Connectivity Between Anterior Default Mode and Sensory Processing Regions Is Linked to Peripheral Inflammatory Markers and Psychopathology in Schizophrenia
Emanuel Mlynek, Xiaolin Tan, Sarah E. Lammertz, et al.
Schizophrenia Bulletin (2025)
Closed Access
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies
Jacopo Sapienza, Marco Spangaro, Gilles J. Guillemin, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 6, pp. 1317-1328
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top